Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M21,667Revenue $M6,909Net Margin (%)12.4Z-Score2.2
Enterprise Value $M29,567EPS $1.6Operating Margin %16.6F-Score6
P/E(ttm))24.9Cash Flow Per Share $3.2Pre-tax Margin (%)12.0Higher ROA y-yY
Price/Book6.410-y EBITDA Growth Rate %11.7Quick Ratio0.9Cash flow > EarningsY
Price/Sales3.15-y EBITDA Growth Rate %9.9Current Ratio1.3Lower Leverage y-yY
Price/Cash Flow8.5y-y EBITDA Growth Rate %13.8ROA % (ttm)6.2Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)28.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M374ROI % (ttm)4.4Gross Margin Increase y-yY

Gurus Latest Trades with MYL

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MYLJohn Paulson 2014-12-31 Add0.72%$46.5 - $58.62
($53.92)
$ 57.897%Add 19.64%14,948,400
MYLJoel Greenblatt 2014-12-31 Buy 0.31%$46.5 - $58.62
($53.92)
$ 57.897%New holding, 673287 sh.673,287
MYLScott Black 2014-12-31 Reduce-0.11%$46.5 - $58.62
($53.8)
$ 57.898%Reduce -8.83%181,796
MYLVanguard Health Care Fund 2014-09-30 Add1.24%$44.97 - $52.34
($48.56)
$ 57.8919%Add 223.41%15,444,880
MYLRay Dalio 2014-09-30 Buy 0.02%$44.97 - $52.34
($48.56)
$ 57.8919%New holding, 57106 sh.57,106
MYLMario Gabelli 2014-09-30 Reduce$44.97 - $52.34
($48.56)
$ 57.8919%Reduce -27.54%10,000
MYLJean-Marie Eveillard 2014-09-30 Reduce-0.06%$44.97 - $52.34
($48.56)
$ 57.8919%Reduce -34.81%809,603
MYLJean-Marie Eveillard 2014-06-30 Add0.07%$45.72 - $52.1
($49.11)
$ 57.8918%Add 83.88%1,241,991
MYLScott Black 2014-06-30 Reduce-0.4%$45.72 - $52.1
($49.11)
$ 57.8918%Reduce -26.46%201,925
MYLAndreas Halvorsen 2014-06-30 Sold Out -0.36%$45.72 - $52.1
($49.11)
$ 57.8918%Sold Out0
MYLAndreas Halvorsen 2014-03-31 Buy 0.36%$42.26 - $57.2
($48.38)
$ 57.8920%New holding, 1776108 sh.1,776,108
MYLJean-Marie Eveillard 2014-03-31 Buy 0.09%$42.26 - $57.2
($48.38)
$ 57.8920%New holding, 675428 sh.675,428
MYLDavid Dreman 2014-03-31 Sold Out $42.26 - $57.2
($48.38)
$ 57.8920%Sold Out0
MYLJohn Hussman 2014-03-31 Reduce-0.47%$42.26 - $57.2
($48.13)
$ 57.8920%Reduce -75%50,000
MYLScott Black 2014-03-31 Reduce-0.16%$42.26 - $57.2
($48.13)
$ 57.8920%Reduce -10.63%274,571
MYLJoel Greenblatt 2014-03-31 Sold Out -0.01%$42.26 - $57.2
($48.38)
$ 57.8920%Sold Out0
MYLDavid Dreman 2013-12-31 Buy $37.865 - $44.5
($41.09)
$ 57.8941%New holding, 1221 sh.1,221
MYLJoel Greenblatt 2013-12-31 Reduce$37.865 - $44.5
($41.09)
$ 57.8941%Reduce -31.83%7,291
MYLJohn Hussman 2013-12-31 Reduce-0.53%$37.865 - $44.5
($41.09)
$ 57.8941%Reduce -55.95%200,000
MYLScott Black 2013-12-31 Reduce-0.23%$37.865 - $44.5
($41.09)
$ 57.8941%Reduce -14.62%307,214
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MYL is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
MYL Joel Greenblatt 2014-12-31673,2870.180.31New Buy
MYL John Paulson 2014-12-3114,948,4003.994.4+19.64%
MYL Jean-Marie Eveillard 2014-12-31841,7790.220.12+3.97%
MYL Mario Gabelli 2014-12-3110,00000
MYL John Hussman 2014-12-3150,0000.010.28
MYL Vanguard Health Care Fund 2014-12-3115,037,0804.022-2.64%
MYL Ray Dalio 2014-12-3152,7060.010.02-7.7%
MYL Scott Black 2014-12-31181,7960.051.4-8.83%
Premium Most recent portfolio changes are included for Premium Members only!


MYL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
COURY ROBERT JExecutive Chairman 2015-02-03Sell947,119$52.559.1view
PARRISH MARK WDirector 2015-02-03Sell54,418$53.157.86view
Cindrich Robert JDirector 2015-02-03Sell40,645$53.157.86view
CAMERON WENDYDirector 2015-02-03Sell106,551$53.157.86view
Malik RajivPresident 2015-02-03Sell285,394$53.157.86view
MAROON JOSEPH C MDDirector 2015-02-03Sell136,551$53.157.86view
BRESCH HEATHER MCEO 2015-02-03Sell411,996$53.157.86view
DIMICK NEIL FDirector 2015-02-03Sell19,781$53.157.86view
Piatt Rodney LDirector 2015-02-03Sell46,000$53.157.86view
VANDERVEEN RANDALL LDirector 2015-02-03Sell106,551$53.157.86view

Press Releases about MYL :

    Quarterly/Annual Reports about MYL:

    News about MYL:

    Articles On GuruFocus.com
    Impax Laboratories Inc. Steps Into Profitable Zone Feb 26 2015 
    Gilead Taking Giant Leap To Serve The Hepatitis C Market Of Developing Countries Feb 26 2015 
    John Paulson's Top Buys Feb 21 2015 
    Weekly CFO Sells Highlight: Sherwin-Williams Co, Facebook Inc, Mylan Inc. Feb 08 2015 
    Weekly CEO Sells Highlight: Family Dollar Stores Inc, Texas Instruments Inc, Mylan Inc, and PerkinEl Feb 08 2015 
    Weekly Insider Sells Highlight: MYL, QRVO, HON, JBHT Feb 08 2015 
    Zoetis in a Growing Global Animal Health Industry Dec 03 2014 
    Weekly CFO Sells Highlight: Hospira Inc, Rockwood Holdings Inc, Mylan Inc. Nov 30 2014 
    Scott Black’s Top First Quarter Holdings Apr 23 2014 
    Should You Buy Actavis? Mar 18 2014 


    More From Other Websites
    Intercept Pharmaceuticals (ICPT): Will It Miss Q4 Earnings? - Analyst Blog Feb 28 2015
    Next Week Feb 28 2015
    Mylan inversion deal completed Feb 27 2015
    Will Endo Internationa's (ENDP) Beat on Earnings in Q4? - Analyst Blog Feb 27 2015
    MYLAN INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition... Feb 27 2015
    Will Mylan (MYL) Beat Earnings on New Product Launches? - Analyst Blog Feb 27 2015
    Mylan Signs Exclusive Agreement with Gilead Sciences to Distribute Sovaldi® and Harvoni® in India Feb 27 2015
    Mylan Completes Acquisition Of Abbott's Non-U.S. Developed Markets Specialty And Branded Generics... Feb 27 2015
    12:30 pm Mylan Labs announces the successful completion of the acquisition of Abbott Laboratories'... Feb 27 2015
    Is a Surprise Coming for Mylan (MYL) This Earnings Season? - Tale of the Tape Feb 27 2015
    What Awaits Keryx Biopharmaceuticals (KERX) this Earnings? - Analyst Blog Feb 26 2015
    Lannett Joins Big-Game Hunt For Drugmaker Acquisitions Feb 24 2015
    Watchdog group seeks FDA ban of antifungal tablets Feb 24 2015
    Watchdog group seeks FDA ban of antifungal tablets Feb 24 2015
    Five Top-Rated Medical Stocks To Keep Monitoring Feb 23 2015
    Drugmaker Mylan Takes Part In Pharma Feeding Frenzy Feb 23 2015
    Pharma M&A: Bristol-Myers, Valeant Make Deals Feb 23 2015
    Mylan Specialty to Present Findings from EpiPen4Schools® Program Survey Feb 23 2015
    Mylan Specialty to Present Findings from EpiPen4Schools® Program Survey Feb 23 2015
    Mylan to Distribute Gilead's Hepatitis C Drugs in India Feb 23 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK